Interv Akut Kardiol. 2014;13(2):87-91

Arrhythmogenic right ventricular cardiomyopathy

Luděk Haman
1 . interní kardioangiologická klinika, FN v Hradci Králové a UK v Praze, LF v Hradci Králové

Arrhythmogenic right ventricular cardiomyopathy is a genetic form of cardiomyopathy usually transmitted with an autosomal dominant

pattern. It primary affects the right ventricle, but may involve also left ventricle and lead to biventricular heart failure, ventricular tachyarrhythmia’s

and sudden cardiac death. Pathologically is characterized by myocardial atrophy and fibro-fatty replacement. Diagnosis is difficult

due to broad spectrum of phenotypic variations, therefore diagnostic criteria combined history, electrocardiography, echocardiography and

magnetic resonance imaging have been developed. Basic diagnostic evaluation is early detection, risk stratification and family screening.

Main therapeutic goal is sudden cardiac death prevention – treatment of arrhythmias and cardioverter-defibrilator implantation.

Keywords: arrhythmogenic right ventricular cardiomyopathy, sudden cardiac death, ventricular tachycardia

Published: May 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haman L. Arrhythmogenic right ventricular cardiomyopathy. Interv Akut Kardiol. 2014;13(2):87-91.
Download citation

References

  1. Blomstrőm-Lundqvist C, Sabel KG, Olsson SB. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987; 58(5): 477-488. Go to original source... Go to PubMed...
  2. Manyari DE, Klein GJ, Gulamhusein S, et al. Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? Circulation 1983; 68(2): 251-257. Go to original source... Go to PubMed...
  3. Pinamonti B, Sinagra G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J 1992; 123(3): 711-724. Go to original source... Go to PubMed...
  4. Halogen C, Beaufils P, Azancot I, Baudouy P, Manne B, Slama R. Recurrent ventricular tachycardia due to right ventricular dysplasia. Association with left ventricular anomalies. Arch Mal Coeur Vaiss 1981; 74(9): 113-118.
  5. Nava A, Canciani B, Daliento L, et al. Juvenile sudden death and effort ventricular tachycardias in a family with right ventricular cardiomyopathy. Int J Cardiol 1988; 21(2): 111-126. Go to original source... Go to PubMed...
  6. Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006; 113(13): 1634-1637. Go to original source... Go to PubMed...
  7. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318(3): 129-133. Go to original source... Go to PubMed...
  8. McKoy G, Protonotarios N, Prosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and wooly hair (Naxos disease). Lancet 2000; 355(9221): 2119-2124. Go to original source... Go to PubMed...
  9. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996; 94(5): 983-991. Go to original source... Go to PubMed...
  10. Nava A, Thiene G, Canciani B, et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 1988; 12(5): 1222-1228. Go to original source... Go to PubMed...
  11. Calabrese F, Basso C, Carturan E, Valente M, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol 2006; 15(1): 11-17. Go to original source... Go to PubMed...
  12. Thiene G, Corrado D, Nava A, et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory etiology? Eur Heart J 1991; 12(SupplD): 22-25. Go to original source... Go to PubMed...
  13. Rampazzo A, Nava A, Erne P, et al. A new focus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 1995; 4(11): 2151-2154. Go to original source... Go to PubMed...
  14. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002; 71(5): 1200-1206. Go to original source... Go to PubMed...
  15. van Tintelen JP, Entius MM, Bhuiyan ZA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006; 113(13): 1650-1658. Go to original source... Go to PubMed...
  16. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373(9671): 1289-1300. Go to original source... Go to PubMed...
  17. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10(3): 189-194. Go to original source... Go to PubMed...
  18. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997; 30(6): 1512-1520. Go to original source... Go to PubMed...
  19. Dalal D, Nasir K, Bomba C, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005; 112(25): 3823-3832. Go to original source... Go to PubMed...
  20. Nava A, Thiene G, Canciani B, et al. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias. Int J Cardiol 1992; 35(2): 195-206. Go to original source... Go to PubMed...
  21. Daliento L, Turrini P, Nava A, et al. Arrhythmogenic right ventricular cardiomyopathy on young versus adult patients: similarities and differences. J Am Coll Cardiol 1995; 25(3): 655-664. Go to original source... Go to PubMed...
  22. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71(3): 215-218. Go to original source... Go to PubMed...
  23. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation 2010; 121(13): 1533-1541. Go to original source... Go to PubMed...
  24. Nasir K, Bomba C, Tandri H, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 2004; 110(12): 1527-1534. Go to original source... Go to PubMed...
  25. Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 2005; 14(1): 37-41. Go to original source... Go to PubMed...
  26. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006; 48(5): e247-346. Go to original source... Go to PubMed...
  27. Leclerq JF, Potenza S, Mason-Blanche P, Chastang C, Coumel P. Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1996; 28(3): 720-724. Go to original source... Go to PubMed...
  28. Furlanello F, Bertholdi A, Dallago M, et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 1998; 21(1Pt2): 331-335. Go to original source... Go to PubMed...
  29. Richter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86(1): 29-37. Go to original source... Go to PubMed...
  30. Marcus GM, Glidden DV, Podonsky B, et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC registry. J Am Coll Cardiol 2009; 54(7): 609-615. Go to original source... Go to PubMed...
  31. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2013; 61(3): e6-75. Go to original source... Go to PubMed...
  32. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrilator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation 2003; 108(25): 3084-3091. Go to original source... Go to PubMed...
  33. Corrado D, Calkins H, Link MS, et al. Prophylactic implantable-defibrilator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; 122(12): 1144-1152. Go to original source... Go to PubMed...
  34. Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367(24): 2275-2283. Go to original source... Go to PubMed...
  35. Corrado D, Basso C, Pilichou K, Thiene G. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 2011; 97: 530-539. Go to original source... Go to PubMed...
  36. Hrošová M, Fiala M, Škňouřil L, et al. Long-term results of catheter ablation for ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Cor et Vasa 2013; 55: e15-e24. Go to original source...
  37. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2009; 120(5): 366-375. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.